These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28240587)

  • 41. Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study.
    Fong W; Woon TH; Kwan YH; Braun J; van der Heijde D; Boonen A; Kiltz U
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
    Maksymowych WP; Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Van den Bosch F; Logeart I; Wajdula J; Jones H; Marshall L; Bonin R; Pedersen R; Vlahos B; Kotak S; Bukowski JF
    Ann Rheum Dis; 2016 Jul; 75(7):1328-35. PubMed ID: 26269397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J
    J Rheumatol; 2004 Mar; 31(3):531-8. PubMed ID: 14994401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?
    Keat A; Bennett AN; Gaffney K; Marzo-Ortega H; Sengupta R; Everiss T
    Rheumatol Int; 2017 Mar; 37(3):327-336. PubMed ID: 28035438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
    Sayın S; Yurdakul FG; Sivas F; Bodur H
    Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.
    Perrotta FM; Addimanda O; Ramonda R; D'Angelo S; Lubrano E; Marchesoni A; Olivieri I; Punzi L; Salvarani C; Spadaro A
    Reumatismo; 2014 Nov; 66(3):208-14. PubMed ID: 25376955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany].
    Brandt J; Westhoff G; Rudwaleit M; Listing J; Zink A; Braun J; Sieper J
    Z Rheumatol; 2003 Jun; 62(3):264-73. PubMed ID: 12827403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The efficacy of etanercept in enthesitis in ankylosing spondylitis and an evaluation method for enthesitis].
    Zhang J; Huang F; Zhang JL; Zhang H; Zhang YM
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):376-9. PubMed ID: 22883337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
    Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
    J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO).
    Min HK; Lee J; Ju JH; Park SH; Kwok SK
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
    Micheroli R; Hebeisen M; Wildi LM; Exer P; Tamborrini G; Bernhard J; Möller B; Zufferey P; Nissen MJ; Scherer A; Ciurea A;
    Arthritis Res Ther; 2017 Jul; 19(1):164. PubMed ID: 28724442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort.
    Bedaiwi M; Sari I; Thavaneswaran A; Ayearst R; Haroon N; Inman RD
    J Rheumatol; 2015 Dec; 42(12):2354-60. PubMed ID: 26523020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National Register.
    Macfarlane GJ; Barnish MS; Pathan E; Martin KR; Haywood KL; Siebert S; Packham J; Atzeni F; Jones GT
    Arthritis Rheumatol; 2017 Nov; 69(11):2144-2150. PubMed ID: 28622461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasonographic evaluation of Achilles tendon: Is there any difference between ankylosing spondylitis, non-radiographic axial spondyloarthropathy and controls?
    Vahidfar S; Sunar İ; Ataman Ş; Yılmaz G; Azarabadi JM; Bölükbaşı A
    Int J Rheum Dis; 2020 Apr; 23(4):511-519. PubMed ID: 31985181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results.
    Deodhar AA; Mease PJ; Rahman P; Navarro-Compán V; Strand V; Hunter T; Bolce R; Leon L; Lauzon S; Marzo-Ortega H
    BMC Rheumatol; 2021 Sep; 5(1):35. PubMed ID: 34538257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
    Bello N; Etcheto A; Béal C; Dougados M; Moltó A
    Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.
    Danve A; Reddy A; Vakil-Gilani K; Garg N; Dinno A; Deodhar A
    Clin Rheumatol; 2015 Jan; 34(1):117-24. PubMed ID: 25421013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Six-month response to anti-TNF drugs in axial spondylarthropathy according to the fulfillment or not of New-York criteria for ankylosing spondylitis or French recommendations for anti-TNF use. A "real life" retrospective study on 175 patients.
    Gérard S; le Goff B; Maugars Y; Berthelot JM
    Joint Bone Spine; 2008 Dec; 75(6):680-7. PubMed ID: 18848489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.